An attempt of gene therapy in Duchenne muscular dystrophy : Overexpression of utrophin in transgenic mdx mice

Acta Neurologica Belgica

Volumn 100, Issue 3, 2000, Pages 146-150

  Gillis, J M ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Duchenne dystrophy; Dystrophin; Gene therapy; Mdx mouse; Utrophin

Indexed keywords

CYTOSKELETON PROTEIN; DYSTROPHIN; MEMBRANE PROTEIN; UTRN PROTEIN, MOUSE; UTROPHIN;

ANIMAL; DISEASE MODEL; DUCHENNE MUSCULAR DYSTROPHY; GENE THERAPY; GENETICS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; PHYSIOLOGY; REVIEW; TRANSGENIC MOUSE; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

ANIMALS; CYTOSKELETAL PROTEINS; DISEASE MODELS, ANIMAL; DYSTROPHIN; GENE THERAPY; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MICE, TRANSGENIC; MUSCULAR DYSTROPHY, DUCHENNE; UTROPHIN;

EID: 0034280902     PISSN: 03009009     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. DECONINCK N., RAFAEL J. A., BECKERS-BLEUKX G., KAHN D., DECONINCK A. E., DAVIES K. E., GILLIS J. M. Consequences of the combined deficiency in dystrophin and utrophin on the mechanical properties and myosin composition of limb and respiratory muscles of the mouse. Neuromuscul. Disord., 1998, 8 : 362-370.
2. DECONINCK N., TINSLEY J., DE BACKER F., FISHER R., KAHN D., PHELPS S., DAVIES K., GILLIS J. M. Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nature Med., 1997, 3 : 1216-1221.
3. FARDEAU M., TOMÉ F. M. S., COLLIN H., AUGIER N., PONS F., LéGER J., LéGER J. J. Présence d'une protéine de type dystrophine au niveau de la jonction neuromusculaire dans la dystrophie musculaire de Duchenne et la souris mutante "mdx". C.R.Acad.Sci.Paris, 1990, 311 : 197-204.
4. GAILLY P., BOLAND B., HIMPENS B., CASTEELS R., GILLIS J. M. Critical evaluation of cytosolic calcium determination in resting muscle fibres from normal and dystrophic (mdx) mice. Cell Calcium, 1993, 14 : 473-483.
5. GILLIS J. M. Membrane abnormalities and Ca homeostasis in muscles of the mdx mouse, an animal model of the Duchenne muscular dystrophy : a review. Acta Physiol. Scand., 1996, 156 : 397-406.
6. GILLIS J. M. Understanding dystrophinopathies : an inventory of the structural and functional consequences of the absence of dystrophin in muscles of the mdx mouse [In Process Citation]. J. Muscle Res. Cell Motil., 1999, 20 : 605-625.
7. GOUDEMANT J. F., DECONINCK N., TINSLEY J. M., ROBERT A., DAVIES K., GILLIS J. M. Expression of truncated utrophin improves pH recovery in exercising muscles of dystrophic mdx mice. A 31P NMR study. Neuromuscul. Disord., 1998, 8 : 371-379.
8. HOFFMAN E. P., BROWN R. H., KUNKEL L. M. Dystrophin : the protein product of the Duchenne muscular dystrophy locus. Cell, 1987, 51 : 919-928.
9. HOFFMAN E. P., FISCHBECK K. H., BROWN R. H., JOHNSON M., MEDORI R., LOIKE J. D., HARRIS J. B., WATERSON R., BROOKE M., SPECHT L., KUPSKY W., CHAMBERLAIN J., CASKEY C. T., SHAPIRO F., KUNKELL M. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N. Engl. J. Med., 1988, 318 : 1363-1368.
10. IMBERT N., VANDEBROUCK C., CONSTANTIN B., DUPORT G., GUILLOU C., COGNARD C., RAYMOND G. Hypoosmotic shocks induce elevation of resting calcium level in Duchenne muscular dystrophy myotubes contracting in vitro. Neuromusc. Disord., 1996, 6 : 351-360.
11. MATSUMURA K., CAMPBELL K. P. Dystrophin-glycoprotein complex : its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve, 1994, 17 : 2-15.
12. MIZUMO Y., NONAKA I., HIRAI S., OZAWA E. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD carriers and control subjects. J. Neurol.Sci., 1993, 119 : 43-52.
13. MOENS P., BAATSEN P. H. W. W., MARÉCHAL G. Increased susceptibility of EDL muscles from mdx mice to damage induced by contractions with stretch. J. Muscle Res. Cell Motil., 1993, 14 : 446-451.
14. TINSLEY J., DECONINCK N., FISHER R., KAHN D., PHELPS S., GILLIS J. M., DAVIES K. Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nature Med., 1998, 4 : 1441-1444.
15. TINSLEY J. M., POTTER A. C., PHELPS S. R., FISHER R., TRICKETT J. I. , DAVIES K. E. Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature, 1996, 384 : 349-353.
16. TINSLEY J. M., BLAKE D. J., ROCHE A., FAIRBROTHER U., RISS J., BYTH B. C., KNIGHT A. E., KENDRICK-JONES J., SUTHERS G. K., LOVE D. R., EDWARDS Y. H., DAVIES K. E. Primary structure of dystrophin-related protein. Nature, 1992, 360 : 591-592.
17. TINSLEY J. M., DAVIES K. E. Utrophin : A potential replacement for dystrophin ? Neuromuscular Disorders., 1993, 3 : 537-539.
18. TURNER P. R., FONG P., DENETCLAW W. F., STEINHARDT R. A. Increased calcium influx in dystrophic muscle. J. Cell Biol., 1991, 115 : 1701-1712.
19. TURNER P. R., WESTWOOD T., REGEN C. M., STEINHARDT R. A. Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature, 1988, 355 : 735-738.
20. WINDER S. J. The membrane-cytoskeleton interface : the role of dystrophin and utrophin. J. Muscle Res. Cell Motil., 1997, 18 : 617-629.